Related Experiment Video

Updated: Jun 21, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

The impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients

Camila Macedo1, Adriana Zeevi, Carol Bentlejewski

  • 1Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA, USA.

Transplantation
|July 9, 2009
PubMed

Insights

Pediatric transplant recipients with high Epstein-Barr virus (EBV) loads show reduced T-cell responses. The Immuknow test may help identify patients at risk for EBV complications after transplantation.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Virology

Background:

  • Pediatric transplant recipients face increased risk of Epstein-Barr virus (EBV)-driven posttransplant lymphoproliferative disease.
  • Monitoring T-cell immunity is crucial for assessing immune competence in these patients.
  • This study investigates the impact of EBV load on T-cell immunity using clinically applicable tests.

Purpose of the Study:

  • To assess the impact of Epstein-Barr virus (EBV) load on T-cell immunity in pediatric transplant recipients.
  • To evaluate the utility of ATP release assays (Immuknow) for measuring global and EBV-specific T-cell responses.
  • To identify potential correlations between EBV load, T-cell function, and risk of EBV-related complications.

Main Methods:

  • Thirty-five asymptomatic pediatric thoracic transplant patients were grouped by EBV load: undetectable (UVL), low (LVL), and high (HVL).
  • Global and EBV-specific T-cell immunity were assessed using ATP release assays (Cylex Immuknow and T Cell Memory assays).
  • Statistical analysis compared T-cell responses across EBV load groups and correlated CD4+ T-cell ATP levels with EBV loads.

Main Results:

  • Patients with undetectable EBV load (UVL) showed normal T-cell responses.
  • Low EBV load (LVL) patients exhibited enhanced T-cell responses compared to UVL and high EBV load (HVL) groups.
  • HVL patients demonstrated an inverse correlation between CD4+ T-cell ATP levels and EBV viral loads.

Conclusions:

  • Assessing global and EBV-specific T-cell immunity via ATP release provides rapid immune competence evaluation.
  • Further research is needed to determine if suppressed CD4+ T-cell ATP release in HVL patients indicates a risk for posttransplant lymphoproliferative disease.
  • The Immuknow test's potential role in identifying at-risk, asymptomatic HVL patients warrants further longitudinal investigation.
Abstract

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...